ZEPPN Stock Chart & Stats
$254.00
$0.00(0.00%)
At close: 4:00 PM EDT
$254.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$70.00 - $411.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$1.14B
Enterprise Value$222.21
Total Cash (Recent Filing)$721.36M
Total Debt (Recent Filing)$1.67B
Price to Earnings (P/E)―
Beta-0.49
Next Earnings
Nov 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-292.87
Shares Outstanding8,460,126
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.02
Price to Sales (P/S)0.01
P/FCF Ratio-0.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$900.24Price Target Upside254.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Premium MixRevenue growth alongside a richer product mix is a constructive sign for the business model: Q2 sales rose 6.9% and gross margin reached 37.4%. Greater acceptance of higher-end T-Rex and Balance products can support pricing, mix quality, and more durable revenue growth.
HYROX Partnership And Ecosystem ExpansionAn exclusive three-year global HYROX partnership broadens Zepp’s route to customers and embeds Amazfit across training, competition, recovery, and connected apps. The hardware, software, and performance-data integration can deepen ecosystem engagement and strengthen brand differentiation over the coming quarters.
Debt ReductionRetiring US$46.7 million of debt since the beginning of 2023 is a tangible balance-sheet improvement. Lower debt can reduce future financing demands and improve financial flexibility, giving management more room to fund product investment while pursuing its stated profitable-growth path.
Bears Say
Continuing Net LossesProfitability remains unproven despite revenue recovery: Q2 net loss widened to US$11.3 million as foreign-exchange headwinds and higher research, marketing, and brand-building spending weighed on results. Persistent losses could restrict internally funded investment and delay a durable earnings recovery.
Negative Cash GenerationCash generation is not yet dependable: operating and free cash flow were negative in both 2024 and 2025. This means the company has not consistently funded operations internally, increasing reliance on cash reserves or balance-sheet support if losses continue over the next several quarters.
Rising LeverageDebt-to-equity reached about 1.06 in 2025, up from a lower leverage profile in 2020–2023, while ROE has remained negative since 2022. Rising leverage alongside losses reduces financial flexibility and leaves less capacity to absorb setbacks or finance growth without added funding pressure.
Zepp Health News
ZEPPN FAQ
What was Zepp Health’s price range in the past 12 months?
Zepp Health lowest stock price was $70.00 and its highest was $411.00 in the past 12 months.
What is Zepp Health’s market cap?
Zepp Health’s market cap is $1.14B.
When is Zepp Health’s upcoming earnings report date?
Zepp Health’s upcoming earnings report date is Nov 23, 2026 which is in 69 days.
How were Zepp Health’s earnings last quarter?
Zepp Health released its earnings results on Sep 02, 2026. The company reported -$0.849 earnings per share for the quarter.
Is Zepp Health overvalued?
According to Wall Street analysts Zepp Health’s price is currently Undervalued.
Does Zepp Health pay dividends?
Zepp Health does not currently pay dividends.
What is Zepp Health’s EPS estimate?
Zepp Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zepp Health have?
Zepp Health has 8,460,126 shares outstanding.
What happened to Zepp Health’s price movement after its last earnings report?
Zepp Health reported an EPS of -$0.849 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Zepp Health?
Currently, no hedge funds are holding shares in MX:ZEPPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zepp Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$900.24 (254.43% Upside)
$900.24 (254.43% Upside)
Blogger Sentiment
Bullish
MX:ZEPPN Sentiment 100%
Sector Average 61%
Sector Average 61%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.84%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Zepp Health
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
ZEPPN Company Deck
ZEPPN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was broadly optimistic, with strong 33.8% revenue growth, higher average selling prices, year-over-year gross-margin expansion, market-share gains, product launches, and progress toward profitable growth. The main challenges were near-term memory-cost pressure, foreign-exchange headwinds, continued operating and net losses, higher operating expenses, and a lower second-quarter growth range. The positive operating and strategic developments significantly outweighed the stated challenges.View all MX:ZEPPN earnings summariesZEPPN Stock 12 Month Forecast
Average Price Target
$900.24
▲(254.43% Upside)